Sign In
Sign Out
My Account
Subscribe
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
Special reports
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 24, 1998
View Archived Issues
Procyon receives Japanese patent for prostate cancer treatment
Read More
PowderJect delivery of DNA vaccines validated in preclinical study
Read More
Expanded approval requested for chemoprotective agent
Read More
Myriad Genetics: Q4 and FY 1998 highlights
Read More
More on NPY receptor antagonists developed at Banyu
Read More
Mitsui Chemicals prepares cell adhesion inhibitors
Read More
Hydroxamic acids as cancer cell differentiation inducers under study at Mitsui Chemicals
Read More
Another series of DC-107 derivatives from Kyowa Hakko particularly useful as antitumor agents
Read More
Belgian academic researchers prepare bioisosteres of BM-34 as new anticonvulsants
Read More
OraPharma begins collaboration with U.N.C. for dental and related diseases
Read More
Isis Pharmaceuticals receives milestone payment from Ciba Vision for Vitravene
Read More
New paclitaxel formulation enters clinical trials
Read More
TheraTech receives NIH funding for novel approach to rheumatoid arthritis
Read More
Cangene signs WinRho distribution agreement for Australia
Read More
Biomira and Biovector collaborate on development of idiotypic B-cell lymphoma vaccine
Read More
Tranzyme obtains technology license from U. of Alabama
Read More
Enzon's PEG-Intron A advances to phase III trials for malignant melanoma
Read More
Phase III trials initiated for desloratadine
Read More
Pierre Fabre obtains good results with RSV subunit vaccine in monkey model
Read More
HemispheRx broadens hepatitis C portfolio
Read More
Meiji Seika profiles preclinical activity of new parenteral cephalosporin
Read More
Caelyx receives approval in Canada
Read More
Safety studies support pediatric use of MKC-442
Read More
Independent investigators report efficacy of Eisai cephalosporin
Read More
Postmarketing study of Vaqta supports safety of hepatitis A vaccine
Read More
Lobucavir is safe and effective in controlling herpes recurrences
Read More
BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe